BET v1 (aa 1-74) Specific Neutra™ Antibody (V3S-0324-FY21), Human IgG4 (CAT#: V3S-0324-FY21)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description BET v1 (aa 1-74) Antibody (V3S-0324-FY21) is a human IgG4 antibody. It has been observed to augment the binding of IgE to Bet v 1, thereby qualifying as an 'enhancing antibody'. BET v1 (aa 75-160) Antibody (V3S-0324-FY22) is a human IgG1 monoclonal antibody. It can special recognized the epitope of AA 75-160 for Bet v 1. Antibody (V3S-0324-FY22) blocked IgE anti-Bet v 1 reactivity. Conversely, BET v1 (aa 75-160) antibody (V3S-0324-FY22) impedes the binding of IgE from atopic patients to Bet v 1, while antibody (V3S-0324-FY21) promotes it.
Clonality Monoclonal
Host Species Human
Target Species Human
Epitope Amino acids 1-74
Isotype Human IgG4

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application WB; ELISA; Block
Application Notes ELISA: 0.2 µg/mL

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target BET v1
Alternative Name Bet v I allergen; the major birch pollen allergen; Betula pendula allergen 1
Research Area Immunology
For research use only, not directly for clinical use.
banner banner
© 2025 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry